Mind Medicine (MMED), one of the leading pharmaceutical companies exploring possible treatment options with psychedelic drugs, has announced a new stock offering. Mind Medicine (or, MindMed) announced that they have entered into an agreement with Canaccord Genuity Corp. for the purchase of 23,810,000 units of the company for C$1.05 per unit. The offering will raise…